$ARQT
Arcutis Biotherapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$25.22
▼-4.68%-$1.24
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateArcutis Biotherapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is ARQT down today? It is at $25.22 (-4.68%), and our scanner flagged it 129 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment ARQT spikes, and full due diligence on ARQT — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $ARQT 129 times in the last 30 days. Create a free account to track $ARQT, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on ARQT from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for ARQT today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Matsuda Masaru Officer | Sold (automatic/other) | -4K | sold 3.2% | 113K | $92K at $25.00 | Sep 16, 26 |
Welgus Howard G. Director | Sold (automatic/other) | -5K | sold 12% | 36K | $114K at $24.18 | Sep 15, 26 |
Welgus Howard G. Director | Other | 4K | added 11% | 41K | $27K at $6.52 | Sep 15, 26 |
Matsuda Masaru Officer | Sold (automatic/other) | -10K | sold 7.9% | 116K | $250K at $25.03 | Sep 8, 26 |
Curran Terrie Director | Sold (automatic/other) | -38K 0.03% of company | sold 62% | 24K | $956K at $25.03 | Aug 27, 26 |
Curran Terrie Director | Other | 38K 0.03% of company | added 100% | 51K | $287K at $7.51 | Aug 27, 26 |
Curran Terrie Director | Sold (automatic/other) | -1K | sold 4.4% | 24K | $28K at $26.04 | Aug 20, 26 |
Curran Terrie Director | Other | 1K | added 4.6% | 25K | $8K at $7.51 | Aug 20, 26 |
Burnett Patrick Officer | Sold (automatic/other) | -2K | sold 1.4% | 118K | $46K at $27.00 | Aug 19, 26 |
Welgus Howard G. Director | Sold (automatic/other) | -5K | sold 11% | 36K | $124K at $26.18 | Aug 17, 26 |
Welgus Howard G. Director | Other | 4K | added 11% | 41K | $27K at $6.52 | Aug 17, 26 |
Burnett Patrick Officer | Sold (automatic/other) | -7K | sold 5.3% | 119K | $175K at $26.08 | Aug 12, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on ARQT from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for ARQT today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
ARQT last traded at $25.22, down 4.68% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Arcutis Biotherapeutics, Inc. Common Stock (ARQT) is next expected to report earnings on Tuesday, October 27, 2026, about 37 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The ARQT Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged ARQT 129 times in the last 30 days.
ARQT (Arcutis Biotherapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $3.19B in the PHARMACEUTICAL PREPARATIONS sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge ARQT for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$ARQT discussion
Sign in to ask a question or join the discussion.